Succinyl CoA (Succinyl-coenzyme A) sodium 是三羧酸循环中的关键中间代谢物，也是辅酶 A 的关键代谢产物。Succinyl CoA sodium 可由 α-酮戊二酸或丙酰辅酶 A 生物合成。Succinyl CoA sodium 是血红素生物合成和糖异生的重要前体与底物。由钴胺素缺乏引发的 Succinyl CoA sodium 不足与生长迟缓、血红素合成障碍、组织甘氨酸蓄积及神经异常直接相关。Succinyl CoA sodium 可用于研究由营养性维生素 B12 缺乏 (导致 Succinyl-Coenzyme A 合成不足) 引发的代谢、神经和血液系统异常 (如卟啉症)。
多粘菌素B九肽
Polymyxin B nonapeptide 是一种阳离子环肽。Polymyxin B nonapeptide 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力。
Polymyxin B nonapeptide TFA 是一种阳离子环肽。Polymyxin B nonapeptide TFA 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide TFA 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力。
Succinyl CoA (Succinyl-coenzyme A) 是三羧酸循环中的关键中间代谢物，也是辅酶 A 的关键代谢产物。Succinyl CoA 可由 α-酮戊二酸或丙酰辅酶 A 生物合成。Succinyl CoA 是血红素生物合成和糖异生的重要前体与底物。由钴胺素缺乏引发的 Succinyl CoA 不足与生长迟缓、血红素合成障碍、组织甘氨酸蓄积及神经异常直接相关。Succinyl CoA 可用于研究由营养性维生素 B12 缺乏 (导致 Succinyl-Coenzyme A 合成不足) 引发的代谢、神经和血液系统异常 (如卟啉症)。
FastTaq DNA 聚合酶(5'→3' exo-)
FastTaq DNA Polymerase(5'→3' exo-) 是基于 Taq DNA 聚合酶的改良 DNA 聚合酶。FastTaq DNA Polymerase(5'→3' exo-) 缺乏野生型 Taq 的 5'→3' 核酸外切酶活性，保留了野生型 Taq 的 5'→3' DNA 聚合酶活性。
Dichloro(1,2-diaminocyclohexane)platinum(II) 是铂 (II) 类似物，也是奥沙利铂的母体配合物。Dichloro(1,2-diaminocyclohexane)platinum(II) 是一种强效化疗药物，具有广谱抗癌活性、低毒性，并且对多种顺铂耐药癌症无交叉耐药性。
多粘菌素B九肽 (标准品)
Polymyxin B nonapeptide (Standard)是 Polymyxin B nonapeptide 的分析标准品。本产品用于研究及分析应用。Polymyxin B nonapeptide 是一种阳离子环肽。Polymyxin B nonapeptide 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力。
Polymyxin B nonapeptide (TFA) (Standard)是 Polymyxin B nonapeptide (TFA) 的分析标准品。本产品用于研究及分析应用。Polymyxin B nonapeptide TFA 是一种阳离子环肽。Polymyxin B nonapeptide TFA 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide TFA 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力
Succinyl CoA (Succinyl-coenzyme A) disodium 是三羧酸循环中的关键中间代谢物，也是辅酶 A 的关键代谢产物。Succinyl CoA disodium 可由 α-酮戊二酸或丙酰辅酶 A 生物合成。Succinyl CoA disodium 是血红素生物合成和糖异生的重要前体与底物。由钴胺素缺乏引发的 Succinyl CoA disodium 不足与生长迟缓、血红素合成障碍、组织甘氨酸蓄积及神经异常直接相关。Succinyl CoA disodium 可用于研究由营养性维生素 B12 缺乏 (导致 Succinyl-Coenzyme A 合成不足) 引发的代谢、神经和血液系统异常 (如卟啉症)。
Protein protein interactions (PPI) have pivotal roles in life processes. The studies showed that aberrant PPI are associated with various diseases. However, the design of modulators targeting PPI still faces tremendous challenges, such the difficult PPI interfaces for the drug design, lack of ligands reference, lack of guidance rules for the PPI modulators development and high-resolution PPI proteins structures.
The PPI Library comprises molecules of various sizes, frameworks, and shapes ranging from fragment-like entities to macrocyclic derivatives designed as secondary structure mimetics or as epitope mimetics. The designs cover β-turn / loop mimetics and α-helix mimetics. Since helices present at the interface in 62% of all protein-protein interactions. This library focused on designs including mimics with the substitution geometry of an a-helices, as well as designs that mimic the location of “hot-spot” side chains in helix-mediated PPIs.
POI 指目标蛋白（Protein of Interest），即分子胶作用中需被降解或调控功能的致病蛋白或关键功能蛋白。分子胶 POI库是由一系列可特异性结合不同类型 POI 的小分子片段组成的。这些配体作为分子胶的关键组成部分，可与靶蛋白形成稳定结合，为分子胶诱导 POI 与 E3 泛素连接酶相互作用奠定基础，其涵盖的 POI 包括癌症相关的 GSPT1、雄激素受体以及神经退行性疾病相关的异常聚集蛋白等多种类型。
该片段库可应用于靶向蛋白降解剂筛选与优化，通过筛选库中对特定 POI 亲和力高、选择性强的配体，可以发现核心结构，开发新型分子胶，如针对 GSPT1 的配体经优化后，得到了降解活性更优的分子胶降解剂。由于许多 POI 因缺乏传统小分子结合口袋难以成药，POI 配体库中部分配体可通过诱导蛋白相互作用的方式调控这类 POI，进一步拓展 “不可成药” 靶标药物研发空间。
多粘菌素B九肽
Polymyxin B nonapeptide 是一种阳离子环肽。Polymyxin B nonapeptide 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力。
Polymyxin B nonapeptide TFA 是一种阳离子环肽。Polymyxin B nonapeptide TFA 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide TFA 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力。
多粘菌素B九肽 (标准品)
Polymyxin B nonapeptide (Standard)是 Polymyxin B nonapeptide 的分析标准品。本产品用于研究及分析应用。Polymyxin B nonapeptide 是一种阳离子环肽。Polymyxin B nonapeptide 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力。
Polymyxin B nonapeptide (TFA) (Standard)是 Polymyxin B nonapeptide (TFA) 的分析标准品。本产品用于研究及分析应用。Polymyxin B nonapeptide TFA 是一种阳离子环肽。Polymyxin B nonapeptide TFA 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide TFA 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力
Succinyl CoA (Succinyl-coenzyme A) sodium 是三羧酸循环中的关键中间代谢物，也是辅酶 A 的关键代谢产物。Succinyl CoA sodium 可由 α-酮戊二酸或丙酰辅酶 A 生物合成。Succinyl CoA sodium 是血红素生物合成和糖异生的重要前体与底物。由钴胺素缺乏引发的 Succinyl CoA sodium 不足与生长迟缓、血红素合成障碍、组织甘氨酸蓄积及神经异常直接相关。Succinyl CoA sodium 可用于研究由营养性维生素 B12 缺乏 (导致 Succinyl-Coenzyme A 合成不足) 引发的代谢、神经和血液系统异常 (如卟啉症)。
Succinyl CoA (Succinyl-coenzyme A) 是三羧酸循环中的关键中间代谢物，也是辅酶 A 的关键代谢产物。Succinyl CoA 可由 α-酮戊二酸或丙酰辅酶 A 生物合成。Succinyl CoA 是血红素生物合成和糖异生的重要前体与底物。由钴胺素缺乏引发的 Succinyl CoA 不足与生长迟缓、血红素合成障碍、组织甘氨酸蓄积及神经异常直接相关。Succinyl CoA 可用于研究由营养性维生素 B12 缺乏 (导致 Succinyl-Coenzyme A 合成不足) 引发的代谢、神经和血液系统异常 (如卟啉症)。
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
MedchemExpress Validation 03
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
MedchemExpress Validation 04
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
